Weight cut not always cosmetic surgery, says consumer court

Ahmedabad: Weight reduction surgery is not always cosmetic surgery and the insurance company is liable to pay for it when it is performed to avoid multiple health complications which may prove life threatening for a patient, a consumer court observed this and asked the insurer to pay 3.17 lakh spent towards the treatment by the patient in the case.

The case involves a 64-year-old resident of Thaltej area, Leenaben Desai, who had weighed 102kg. She had a Rs 5 lakh mediclaim cover from the New India Assurance Co Ltd. She was suffering from hyper acidity and gastroesophageal reflux disease (GERD), which is a chronic disease.

Desai’s physician referred her to a bariatric and gastroenterology surgeon, Dr Chirag Desai, who advised her for laparoscopic mini gastric bypass surgery because she was suffering from GERD, hyper acidity as well as fatty liver and morbid obesity. She underwent the surgery in May 2016 and paid Rs3.17 lakh for the treatment.

The patient claimed the amount on the medical bill but the insurer repudiated her claim a month later saying that obesity treatment and its complications are excluded from the scope of the mediclaim policy.

Desai sued the insurer with the Consumer Dispute Redressal Forum, Ahmedabad city last year. The court last week ordered the insurance company to reimburse the medical bill with 8% interest as well as Rs 5,000 compensation towards causing mental agony and legal expenditure.

Before awarding the refund to the patient, the consumer court said that the complainant was aged 64 years and her weight was 102 kg. The surgery was intended to address hypertension and morbid obesity. “In our opinion, the complainant did not undergo surgery to improve her physical appearance nor was it a cosmetic surgery considering her age at 64, but, in fact, it was aimed at ensuring that she does not develop complications which may later prove life threatening,” the court said.

The court also refused to buy the insurer’s argument that this surgery was excluded from the policy by a specific clause. It said that company had not spelt out as to how the policy clause was applicable to the case and why her claim was not admissible.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Boehringer Ingelheim launches AI centre for pharma research in London

    Boehringer Ingelheim launches AI centre for pharma research in London

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March